Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zalviso vs Morphine IV PCA for Post-Operative Pain
NCT01539538Phase 3Completed
- Sponsor
- Talphera
- Start
- Apr 2012
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sufentanil in postoperative pain (2 arms), sponsored by Talphera. Primary endpoint: Patient Global Assessment of method of pain control at 48 hours. Started Apr 2012; status: completed.
02
Drugs
sufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01539538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01539538.